Cargando…

Revisiting the use of graph centrality models in biological pathway analysis

The use of graph theory models is widespread in biological pathway analyses as it is often desired to evaluate the position of genes and proteins in their interaction networks of the biological systems. In this article, we argue that the common standard graph centrality measures do not sufficiently...

Descripción completa

Detalles Bibliográficos
Autores principales: Naderi Yeganeh, Pourya, Richardson, Chrsitine, Saule, Erik, Loraine, Ann, Taghi Mostafavi, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296696/
https://www.ncbi.nlm.nih.gov/pubmed/32549913
http://dx.doi.org/10.1186/s13040-020-00214-x
_version_ 1783546884750573568
author Naderi Yeganeh, Pourya
Richardson, Chrsitine
Saule, Erik
Loraine, Ann
Taghi Mostafavi, M.
author_facet Naderi Yeganeh, Pourya
Richardson, Chrsitine
Saule, Erik
Loraine, Ann
Taghi Mostafavi, M.
author_sort Naderi Yeganeh, Pourya
collection PubMed
description The use of graph theory models is widespread in biological pathway analyses as it is often desired to evaluate the position of genes and proteins in their interaction networks of the biological systems. In this article, we argue that the common standard graph centrality measures do not sufficiently capture the informative topological organizations of the pathways, and thus, limit the biological inference. While key pathway elements may appear both upstream and downstream in pathways, standard directed graph centralities attribute significant topological importance to the upstream elements and evaluate the downstream elements as having no importance.We present a directed graph framework, Source/Sink Centrality (SSC), to address the limitations of standard models. SSC separately measures the importance of a node in the upstream and the downstream of a pathway, as a sender and a receiver of biological signals, and combines the two terms for evaluating the centrality. To validate SSC, we evaluate the topological position of known human cancer genes and mouse lethal genes in their respective KEGG annotated pathways and show that SSC-derived centralities provide an effective framework for associating higher positional importance to the genes with higher importance from a priori knowledge. While the presented work challenges some of the modeling assumptions in the common pathway analyses, it provides a straight-forward methodology to extend the existing models. The SSC extensions can result in more informative topological description of pathways, and thus, more informative biological inference.
format Online
Article
Text
id pubmed-7296696
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72966962020-06-16 Revisiting the use of graph centrality models in biological pathway analysis Naderi Yeganeh, Pourya Richardson, Chrsitine Saule, Erik Loraine, Ann Taghi Mostafavi, M. BioData Min Research The use of graph theory models is widespread in biological pathway analyses as it is often desired to evaluate the position of genes and proteins in their interaction networks of the biological systems. In this article, we argue that the common standard graph centrality measures do not sufficiently capture the informative topological organizations of the pathways, and thus, limit the biological inference. While key pathway elements may appear both upstream and downstream in pathways, standard directed graph centralities attribute significant topological importance to the upstream elements and evaluate the downstream elements as having no importance.We present a directed graph framework, Source/Sink Centrality (SSC), to address the limitations of standard models. SSC separately measures the importance of a node in the upstream and the downstream of a pathway, as a sender and a receiver of biological signals, and combines the two terms for evaluating the centrality. To validate SSC, we evaluate the topological position of known human cancer genes and mouse lethal genes in their respective KEGG annotated pathways and show that SSC-derived centralities provide an effective framework for associating higher positional importance to the genes with higher importance from a priori knowledge. While the presented work challenges some of the modeling assumptions in the common pathway analyses, it provides a straight-forward methodology to extend the existing models. The SSC extensions can result in more informative topological description of pathways, and thus, more informative biological inference. BioMed Central 2020-06-16 /pmc/articles/PMC7296696/ /pubmed/32549913 http://dx.doi.org/10.1186/s13040-020-00214-x Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Naderi Yeganeh, Pourya
Richardson, Chrsitine
Saule, Erik
Loraine, Ann
Taghi Mostafavi, M.
Revisiting the use of graph centrality models in biological pathway analysis
title Revisiting the use of graph centrality models in biological pathway analysis
title_full Revisiting the use of graph centrality models in biological pathway analysis
title_fullStr Revisiting the use of graph centrality models in biological pathway analysis
title_full_unstemmed Revisiting the use of graph centrality models in biological pathway analysis
title_short Revisiting the use of graph centrality models in biological pathway analysis
title_sort revisiting the use of graph centrality models in biological pathway analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296696/
https://www.ncbi.nlm.nih.gov/pubmed/32549913
http://dx.doi.org/10.1186/s13040-020-00214-x
work_keys_str_mv AT naderiyeganehpourya revisitingtheuseofgraphcentralitymodelsinbiologicalpathwayanalysis
AT richardsonchrsitine revisitingtheuseofgraphcentralitymodelsinbiologicalpathwayanalysis
AT sauleerik revisitingtheuseofgraphcentralitymodelsinbiologicalpathwayanalysis
AT loraineann revisitingtheuseofgraphcentralitymodelsinbiologicalpathwayanalysis
AT taghimostafavim revisitingtheuseofgraphcentralitymodelsinbiologicalpathwayanalysis